Detalhe da pesquisa
1.
HMGA1 regulates trabectedin sensitivity in advanced soft-tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) study.
Cell Mol Life Sci
; 81(1): 219, 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38758230
2.
ISG15 as a prognostic biomarker in solitary fibrous tumour.
Cell Mol Life Sci
; 79(8): 434, 2022 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35864381
3.
Efficacy of Eribulin Plus Gemcitabine Combination in L-Sarcomas.
Int J Mol Sci
; 24(1)2022 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36614121
4.
Erratum: Hindi, N., et al. Trabectedin Plus Radiotherapy for Advanced Soft-Tissue Sarcoma: Experience in Forty Patients Treated at a Sarcoma Reference Center. Cancers 2020, 12, 3740.
Cancers (Basel)
; 13(7)2021 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33805586
5.
Cancer Stem Cells in Soft-Tissue Sarcomas.
Cells
; 9(6)2020 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32532153
6.
Trabectedin Plus Radiotherapy for Advanced Soft-Tissue Sarcoma: Experience in Forty Patients Treated at a Sarcoma Reference Center.
Cancers (Basel)
; 12(12)2020 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33322663
7.
CUL4A, ERCC5, and ERCC1 as Predictive Factors for Trabectedin Efficacy in Advanced Soft Tissue Sarcomas (STS): A Spanish Group for Sarcoma Research (GEIS) Study.
Cancers (Basel)
; 12(5)2020 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32365979
8.
Assessment of Safety and Efficacy of Combined Trabectedin and Low-Dose Radiotherapy for Patients With Metastatic Soft-Tissue Sarcomas: A Nonrandomized Phase 1/2 Clinical Trial.
JAMA Oncol
; 6(4): 535-541, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32077895